The cost-effectiveness of tiotropium for the treatment of chronic obstructive pulmonary disease (COPD): the importance of the comparator

The cost-effectiveness of tiotropium for the treatment of chronic obstructive pulmonary disease (COPD): the importance of the comparator

Show other versions (1)

Bibliographic Details
Main Authors:	Neyt, M, Van Den Bruel, A
Format:	Journal article
Published:	2012

Similar Items

The cost-effectiveness of tiotropium for the treatment of chronic obstructive pulmonary disease (COPD): the importance of the comparator.
by: Neyt, M, et al.
Published: (2012)

Does tiotropium lower exacerbation and hospitalization frequency in COPD patients: results of a meta-analysis
by: Gailly Jeannine, et al.
Published: (2010-09-01)

Evaluating the cost-effectiveness of tiotropium versus salmeterol in the treatment of chronic obstructive pulmonary disease
by: Shalini Naik, et al.
Published: (2010-03-01)

Tiotropium bromide: role in the treatment of chronic obstructive pulmonary disease
by: A I Sinopalnikov
Published: (2004-03-01)

Cost-effectiveness of umeclidinium compared with tiotropium and glycopyrronium as monotherapy for chronic obstructive pulmonary disease: a UK perspective
by: Dhvani Shah, et al.
Published: (2018-05-01)

Tiotropium in chronic obstructive pulmonary disease – a review of clinical development
by: Antonio Anzueto, et al.
Published: (2020-07-01)

Tiotropium - Advancing the treatment of COPD
by: Chambers, S, et al.
Published: (2008)

The Efficacy and Cost-Effectiveness of Umeclidinium/Vilanterol versus Tiotropium in Symptomatic Patients with Chronic Obstructive Pulmonary Disease
by: Yinhua Gong, et al.
Published: (2022-01-01)

Comparative Study on the effectiveness of Glycopyrrolate/Formoterol versus Tiotropium/Formoterol in patients with Chronic Obstructive Pulmonary Disease
by: Nalini Jayanthi, et al.
Published: (2022-08-01)

Cost-Effectiveness Analysis of Fixed-Dose Tiotropium/Olodaterol versus Tiotropium for COPD Patients in China
by: Lan Y, et al.
Published: (2023-09-01)

Outcomes associated with initiation of tiotropium or fluticasone/salmeterol in patients with chronic obstructive pulmonary disease
by: Halpern R, et al.
Published: (2011-07-01)

Legal demands of the tiotropium bromide for treatment of chronic obstructive pulmonary disease and their financial impact for the State of Paraná, Brazil
by: Renata Szpak, et al.

Combined bronchodilators (tiotropium plus olodaterol) for patients with chronic obstructive pulmonary disease
by: Ramadan WH, et al.
Published: (2015-10-01)

Effects of tiotropium on sympathetic activation during exercise in stable chronic obstructive pulmonary disease patients
by: Kitada S, et al.
Published: (2012-05-01)

Direct Switch from Tiotropium to Indacaterol/Glycopyrronium in Chronic Obstructive Pulmonary Disease Patients in Korea
by: Sang Haak Lee, et al.
Published: (2021-04-01)

Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK
by: Eklund O, et al.
Published: (2016-06-01)

Changes in functional status and inflammation profile in patients with chronic obstructive pulmonary disease during therapy with tiotropium
by: I. N. Trofimenko, et al.
Published: (2015-12-01)

Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease
by: Miravitlles M, et al.
Published: (2015-03-01)

Clinical trial design in chronic obstructive pulmonary disease: current perspectives and considerations with regard to blinding of tiotropium
by: Beeh Kai-Michael, et al.
Published: (2012-06-01)

Tiotropium as essential maintenance therapy in COPD
by: M. Decramer
Published: (2006-12-01)

Efficacy of tiotropium in the prevention of exacerbations of COPD
by: Antonio Anzueto, et al.
Published: (2009-06-01)

Chronic obstructive pulmonary disease (COPD) and COPD-like phenotypes
by: Spyridon Fortis, et al.
Published: (2024-04-01)

Approach to: Chronic obstructive pulmonary disease (COPD)
by: Alexander Ni
Published: (2020-10-01)

Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study
by: Ichinose M, et al.
Published: (2018-07-01)

Lung function and long-term safety of tiotropium/olodaterol in East Asian patients with chronic obstructive pulmonary disease
by: Bai C, et al.
Published: (2017-11-01)

Sequential comparison of tiotropium to high-dose ipratropium in patients with chronic obstructive pulmonary disease in a practice setting
by: Umair Gauhar, et al.
Published: (2009-10-01)

Is stratification testing for treatment of chronic obstructive pulmonary disease exacerbations cost-effective in primary care? An early cost-utility analysis
by: Abel, L, et al.
Published: (2019)

Education as an important aspect in the care of a patient with Chronic Obstructive Pulmonary Disease (COPD)
by: Agata Ulenberg, et al.
Published: (2017-08-01)

Education as an important aspect in the care of a patient with Chronic Obstructive Pulmonary Disease (COPD)
by: Agata Ulenberg, et al.
Published: (2017-08-01)

COST-EFFECTIVENESS OF VILANEROL / UMECLIDINIUM VERSUS TIOTROPIUM IN SEVERE AND VERY SEVERE COPD
by: E. G. Kosolapov, et al.
Published: (2017-08-01)

Roflumilast: A Review of Chronic Obstructive Pulmonary Disease (COPD) Treatment
by: Ita Octafia, et al.
Published: (2021-01-01)

Tiotropium in COPD: clinical outcomes and economic evidence
by: Orietta Zaniolo, et al.
Published: (2010-03-01)

Factors Associated with Reduction of Sedentary Time Following Tiotropium/Olodaterol Therapy in Treatment-Naïve Chronic Obstructive Pulmonary Disease
by: Takahashi K, et al.
Published: (2021-12-01)

Costs of illness analysis in Italian patients with chronic obstructive pulmonary disease (COPD): an update
by: Dal Negro RW, et al.
Published: (2015-03-01)

Prevalence of chronic obstructive pulmonary disease (COPD) in Albania
by: Holta Tafa, et al.
Published: (2021-02-01)

Chronic obstructive pulmonary disease (COPD) and occupational exposures
by: Zeni Elena, et al.
Published: (2006-06-01)

[Acute exacerbations in Chronic Obstructive Pulmonary Disease (COPD)]
by: Domenico Lorenzo Urso
Published: (2017-07-01)

Book review: Chronic Obstructive Pulmonary Disease (COPD)
by: E. Weitzenblum
Published: (2009-06-01)

Effects of indacaterol versus tiotropium on respiratory mechanics assessed by the forced oscillation technique in patients with chronic obstructive pulmonary disease
by: Inui N, et al.
Published: (2015-06-01)

Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related
by: Koehorst-ter Huurne K, et al.
Published: (2016-07-01)